Related Experiment Video
Updated: Jul 29, 2025
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.3K
Does hormone replacement therapy prevent cognitive decline in postmenopausal women?
Madeline Gates1, Melissa Beagle1, Lauren Bull1
1University of Colorado Family Medicine Residency, Denver.
The Journal of Family Practice
|May 24, 2023
Summary
Hormone replacement therapy (HRT) does not prevent cognitive decline in postmenopausal women. Evidence suggests HRT may slightly increase the risk of cognitive decline, challenging previous assumptions.
Area of Science:
- Neuroscience
- Endocrinology
- Gerontology
Background:
- Cognitive decline is a significant concern for postmenopausal women.
- Hormone replacement therapy (HRT) has been explored as a potential intervention.
Purpose of the Study:
- To evaluate the efficacy of HRT in preventing cognitive decline in postmenopausal women.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Inclusion of individual RCT data for comprehensive analysis.
Main Results:
- Hormone replacement therapy (HRT) demonstrated no preventive effect on cognitive decline.
- A slight increase in the risk of cognitive decline was observed with HRT use.
Conclusions:
- HRT is not recommended for preventing cognitive decline in postmenopausal women.
- The findings challenge the established understanding of HRT's role in cognitive health.
Related Concept Videos
01:28Menopause
210
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
210
01:30Cognitive Development During Adulthood
166
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
166
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
166
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
166
01:22Alzheimer's Disease: Treatment
226
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
226
01:23Role of Neurotransmitters in Memory
678
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
678
01:26Alzheimer's Disease: Overview
541
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
541